发明授权
- 专利标题: N-formyl hydroxylamines
- 专利标题(中): N-甲酰羟胺
-
申请号: US11914659申请日: 2006-05-22
-
公开(公告)号: US07615635B2公开(公告)日: 2009-11-10
- 发明人: Kathryn Rene Bracken , Simon Bushell , Karl Dean , Charles Francavilla , Rakesh K. Jain , Kwangho Lee , Mohindra Seepersaud , Lei Shu , Arathi Sundaram , Zhengyu Yuan
- 申请人: Kathryn Rene Bracken , Simon Bushell , Karl Dean , Charles Francavilla , Rakesh K. Jain , Kwangho Lee , Mohindra Seepersaud , Lei Shu , Arathi Sundaram , Zhengyu Yuan
- 申请人地址: CH Basel AT Vienna
- 专利权人: Novartis AG,Vicuron Pharmaceuticals, Inc.
- 当前专利权人: Novartis AG,Vicuron Pharmaceuticals, Inc.
- 当前专利权人地址: CH Basel AT Vienna
- 代理机构: McCarter & English, LLP
- 代理商 Elizabeth A. Hanley, Esq.; Joshua K. Roth
- 国际申请: PCT/US2006/019688 WO 20060522
- 国际公布: WO2006/127576 WO 20061130
- 主分类号: C07D403/12
- IPC分类号: C07D403/12 ; A61K31/501 ; A61K31/497 ; A61K31/506 ; A61K31/4439 ; C07D401/12 ; C07D309/10 ; C07D207/08 ; A61P31/04
摘要:
Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and use of the compounds are also disclosed.
公开/授权文献
- US20080161558A1 N-Formyl Hydroxylamines 公开/授权日:2008-07-03
信息查询